University of Houston · 1 month ago
Professor - Biomolecular Engineering
Houston, TX
Full-time
Onsite
Director/ExecutiveThe University of Houston is seeking to hire a tenured Full Professor in the field of Biomolecular Engineering, focusing on the molecular design and development of novel therapeutic agents. The successful candidate will collaborate with researchers to employ Artificial Intelligence and Data Science tools to accelerate drug discovery.
E-LearningEducationUniversities
Responsibilities
Collaborate with researchers from UH and the nearby Texas Medical Center
Employ Artificial Intelligence and Data Science tools in combination with innovative experiments to accelerate drug discovery
Qualification
Required
Candidates must have an earned Ph.D. degree or equivalent in a related field
An outstanding record of research accomplishments
Be internationally recognized experts in their field
Industrial experience and a strong track record in translational research would be a plus
Cover Letter
Curriculum Vitae
Research Statement
Teaching Philosophy or Statement
Names and contact information (email address and phone number) of three professional references whom we may contact
Preferred
Research area focusing on the molecular design and development of novel therapeutic agents for debilitating diseases, including cancer, diabetes, cardiovascular disorders, or Alzheimer's
Employing Artificial Intelligence (AI) and Data Science tools in combination with innovative experiments to accelerate drug discovery
Company
University of Houston
The doctoral degree-granting and largest university of the University of Houston system.
Founded in 1927
5001-10000 employees
H1B Sponsorship
University of Houston has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (107)
2024 (76)
2023 (80)
2022 (42)
Funding
Current Stage
Late StageTotal Funding
$9.3MKey Investors
National Institute for Innovation in Manufacturing BiopharmaceuticalsUS Department of EnergyCancer Prevention and Research Institute of Texas
2024-04-09Grant
2023-10-05Grant· $2M
2018-09-19Grant· $4M
Leadership Team
Arthur Conklin
Professor Emeritus
Brené Brown
Huffington Endowed Chair + Research Professor
Recent News
2025-12-04
2025-10-25
Company data provided by crunchbase